Literature DB >> 17078057

Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study.

Alice B Kornblith1, Jeannette M Dowell, James E Herndon, Beverly J Engelman, Susan Bauer-Wu, Eric J Small, Vicki A Morrison, James Atkins, Harvey Jay Cohen, Jimmie C Holland.   

Abstract

BACKGROUND: Significant barriers to cancer patients receiving mental health treatment for distress have been reported in the literature. The objective of the current study was to determine whether distress in older patients (aged 65 years and older) would be reduced with educational materials (EM) supplemented by monthly telephone monitoring (TM) (TM + EM) compared with the use of EM alone because of more timely referrals to appropriate health professionals.
METHODS: One hundred ninety-two older patients with breast, prostate, and colorectal cancers who had advanced disease and currently were receiving treatment were randomized to receive either TM + EM or EM alone. One hundred thirty-one patients were evaluated by telephone interview for psychologic and physical distress and for social support at baseline and at 6 months using the Hospital Anxiety and Depression Scale (HADS), the European Organization for Research and Treatment of Cancer (EORTC)-QLQ-C30 quality-of-life questionnaire, and the Medical Outcomes Study (MOS) Social Support Survey. Patients who in the TM + EM group were called monthly for 6 months to monitor their distress using the HADS and EORTC physical symptom items and the MOS Social Support Survey items, with cutoff levels were established to indicate which patients were in greater distress. Those patients who scored above the cutoff levels were referred to their oncology nurse for referral to the appropriate professional. Patients in the EM group received written materials regarding cancer-related psychosocial issues and available resources.
RESULTS: At 6 months, patients in the TM + EM group reported significantly less anxiety (HADS; P < .0001), depression (HADS; P = .0004), and overall distress (HADS; P < .0001) compared with patients in the EM group.
CONCLUSIONS: Monthly monitoring of older patients' distress with TM and EM along with referral for appropriate help was found to be an efficient means of reducing patients' anxiety and depression compared with patients who received only EM. (c) 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 17078057     DOI: 10.1002/cncr.22296

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.

Authors:  Elyse R Park; Sandra Japuntich; Jennifer Temel; Michael Lanuti; Jennifer Pandiscio; Joanna Hilgenberg; Diane Davies; Carolyn Dresler; Nancy A Rigotti
Journal:  J Thorac Oncol       Date:  2011-06       Impact factor: 15.609

2.  Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.

Authors:  Charles S Cleeland; Xin Shelley Wang; Qiuling Shi; Tito R Mendoza; Sherry L Wright; Madonna D Berry; Donna Malveaux; Pankil K Shah; Ibrahima Gning; Wayne L Hofstetter; Joe B Putnam; Ara A Vaporciyan
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

3.  Integrating tobacco treatment into thoracic oncology settings: Lessons learned.

Authors:  Sandra J Japuntich; Christina M Luberto; Joanna M Streck; Nancy A Rigotti; Jennifer Temel; Michael Lanuti; Carolyn Dresler; Jennifer P Zallen; Diane Davies; Elyse R Park
Journal:  J Health Psychol       Date:  2015-06-04

Review 4.  A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses.

Authors:  Tim Luckett; Phyllis N Butow; Madeleine T King; Mayumi Oguchi; Gaynor Heading; Nadine A Hackl; Nicole Rankin; Melanie A Price
Journal:  Support Care Cancer       Date:  2010-07-02       Impact factor: 3.603

Review 5.  Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication.

Authors:  L Y Yang; D S Manhas; A F Howard; R A Olson
Journal:  Support Care Cancer       Date:  2017-08-28       Impact factor: 3.603

Review 6.  Innovations in research and clinical care using patient-generated health data.

Authors:  Heather S L Jim; Aasha I Hoogland; Naomi C Brownstein; Anna Barata; Adam P Dicker; Hans Knoop; Brian D Gonzalez; Randa Perkins; Dana Rollison; Scott M Gilbert; Ronica Nanda; Anders Berglund; Ross Mitchell; Peter A S Johnstone
Journal:  CA Cancer J Clin       Date:  2020-04-20       Impact factor: 508.702

7.  The modified Memorial Symptom Assessment Scale Short Form: a modified response format and rational scoring rules.

Authors:  J L Sharp; K Gough; M C Pascoe; A Drosdowsky; V T Chang; P Schofield
Journal:  Qual Life Res       Date:  2018-05-21       Impact factor: 4.147

8.  A randomized trial of weekly symptom telemonitoring in advanced lung cancer.

Authors:  Susan E Yount; Nan Rothrock; Michael Bass; Jennifer L Beaumont; Deborah Pach; Thomas Lad; Jyoti Patel; Maria Corona; Rebecca Weiland; Katherine Del Ciello; David Cella
Journal:  J Pain Symptom Manage       Date:  2013-11-07       Impact factor: 3.612

9.  The relationship between age, anxiety, and depression in older adults with cancer.

Authors:  Talia R Weiss Wiesel; Christian J Nelson; William P Tew; Molly Hardt; Supriya Gupta Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Ajeet Gajra; Stuart M Lichtman; Rupal Ramani; Vani Katheria; Laura Zavala; Arti Hurria
Journal:  Psychooncology       Date:  2014-08-06       Impact factor: 3.894

10.  Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients.

Authors:  Catherine E Mosher; Joseph G Winger; Nasser Hanna; Shadia I Jalal; Achilles J Fakiris; Lawrence H Einhorn; Thomas J Birdas; Kenneth A Kesler; Victoria L Champion
Journal:  Psychooncology       Date:  2014-02-03       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.